biospectrumasiaAugust 18, 2019
Tag: Clinithink , Healthix , health data
Clinithink and Healthix – the largest public health information exchange (HIE) in the U.S. are partnering on a program designed to leverage Healthix clinical data to facilitate the assessment of pre-trial feasibility, ensuring the validity of protocol design. The effectiveness of the collaboration will improve population health in New York City and Long Island by eventually making cutting-edge treatments available to patients.
With health data of over 17 million individuals, Healthix spans a comprehensive range of organizations, from large hospital systems and health plans to small community health centres and physician practices. Over one thousand organizations, across more than 7,000 facilities, are connected through Healthix, contributing a rich clinical data set that is updated with each patient encounter. Clinithink’s artificial intelligence and clinical natural language processing (AI/CNLP) platform will run queries on this HIE data to generate insights that can be used to improve patient wellbeing, both now and in the future.
"We are constantly looking for ways to deliver enhanced value to our patients and the healthcare community. Our partnership with Clinithink uniquely positions us to support an important industry need by driving innovation and supporting efficiencies in the design and implementation of clinical trials – all while remaining compliant with New York’s privacy policy guidelines," said Todd M. Rogow, President and CEO of Healthix.
While some health systems have already experienced moderate success in achieving these insights, the key difference for Healthix is that they connect multiple health systems in various settings, making them a valuable partner.
Clinithink CEO Chris Tackaberry said "We are delighted to be partnering with Healthix to unlock the clinical data for such a diverse urban population with challenging healthcare needs. We are confident our tools can help improve clinical outcomes, as well as promote efficiency and reduce the healthcare costs associated with clinical trials and treatment protocols."
"We are incredibly excited that Healthix is becoming our latest AI/CNLP partner. Their large and growing HIE catchment area is projected to serve 20 million people before long, and the insights we can facilitate will, therefore, be even more impactful to the health and wellbeing of patients. Additionally, the expert technical staff at Healthix have expedited implementation and made access to clinical narrative simple and straightforward. We look forward to this being the blueprint for our future HIE partners," added Glenn Keet, General Manager, Healthcare Solutions for Clinithink.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: